Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Naproxen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Naproxen 500mg tablets
1001010P0AAAEAE
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 796,014 |
|
Naproxen 250mg tablets
1001010P0AAADAD
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 290,957 |
|
Naproxen 500mg gastro-resistant tablets
1001010P0AAAIAI
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 95,864 |
|
Naproxen 250mg gastro-resistant tablets
1001010P0AAAHAH
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 55,579 |
|
Naproxen 500mg / Esomeprazole 20mg modified-release tablets
1001010P0AABBBB
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 7,550 |
|
Naproxen 375mg gastro-resistant tablets
1001010P0AAAJAJ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 1,996 |
|
Naproxen 250mg/5ml oral suspension
1001010P0AABFBF
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 1,153 |
|
Naproxen 250mg effervescent tablets sugar free
1001010P0AABDBD
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 887 |
|
Naproxen 125mg/5ml oral suspension sugar free
1001010P0AABEBE
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 233 |
|
Naproxen 200mg/5ml oral suspension
1001010P0AABCBC
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 27 |
|
Naproxen 125mg/5ml oral suspension
1001010P0AAARAR
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 13 |
|
Naproxen 100mg/5ml oral suspension
1001010P0AAAYAY
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 320mg/5ml oral suspension
1001010P0AABIBI
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg modified-release tablets
1001010P0AAAQAQ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg suppositories
1001010P0AABGBG
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg tablets and Misoprostol 200microgram tablets
1001010P0AAALAL
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 500mg/5ml oral suspension
1001010P0AAATAT
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 60mg/5ml oral suspension
1001010P0AABHBH
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 70mg/5ml oral suspension
1001010P0AAAWAW
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Naproxen 75mg/5ml oral suspension
1001010P0AAAZAZ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.